Tag: in-vitro diagnostics market share

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the In Vitro Diagnostics Market’s Growth Trajectory From 2025 To 2034?

The size of the in vitro diagnostics market has seen swift expansion in the last few years. Growth from $121.96 billion in 2024 to $136.55 billion in 2025, delineates a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth during the historic period include the advent of automated analyzers and molecular diagnostics, an aging population, disease outbreaks, healthcare regulations, and personalized medicine.

In the forthcoming years, the size of the in vitro diagnostics market is anticipated to witness substantial growth, expanding to a valuation of $214.88 billion by 2029 with a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth during the projected period include precision medicine, point-of-care testing, advancements in digital health and data analytics, and readiness for pandemics. Prominent trends influencing the forecast period involve technological advancements, incorporation of digital health, individualized diagnostics, testing kits for home use, and molecular diagnostics.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

Which Factors and External Forces Are Driving Demand in the In Vitro Diagnostics Market?

The increasing interest in self-administered testing kits is predicted to stimulate the expansion of the in vitro diagnostics market. These kits are medical or diagnostic tools that individuals can utilize themselves, without the assistance of healthcare professionals or trained personnel at home. They enhance accessibility by providing users the ability to carry out diagnostic tests at their convenience at home which could heighten the demand for testing, particularly for conditions that have not been diagnosed previously. For example, the Centers for Disease Control and Prevention, a US-based national public health agency, recorded a substantial surge in the utilization of at-home COVID-19 tests among US adults aged 18 or older between the Delta-dominant phase (August to December 2021) and the Omicron-dominant phase (December to March 2022). The self-reported use of at-home tests among those presenting COVID-19-like symptoms increased from 5.7% to 20.1%. Thus, the growing appeal of self-administered test kits is expected to fuel the advancement of the in vitro diagnostics market.

Which Segments in the In Vitro Diagnostics Offer the Most Growth?

The in vitro diagnosticsmarket covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the In Vitro Diagnostics Market?# Market?

North America was the largest region in the global in-vitro diagnostics market in 2024. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theIn Vitro Diagnostics Market’s Growth?

Leading enterprises in the in vitro diagnostics market are concentrating their efforts on creating novel products like the Cobas pulse system, to boost their market profitability. The Cobas pulse system, equipped with mobile digital health technology, is a professional tool for managing blood sugar levels and enhancing patient care. In January 2022, Roche Diagnostics, a US-based firm known for its ground-breaking products and services that cover a spectrum from disease prevention and diagnosis to monitoring, screening, and treatment, unveiled the Cobas pulse system. This portable gadget comes with an automatic glucose test strip reader, a camera, and a touchscreen to log additional diagnostic information. Its easy-to-use interface, designed for simple deployment, provides handy features that streamline operations, conserve time and optimize workflows.

View the full report here:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

What Are the Key Elements That Define the In Vitro Diagnostics Market?

In vitro diagnostics (IVD) refer to tests and procedures performed on biological samples, such as blood, tissue, or urine, taken from the human body to detect diseases, conditions, or infections. These tests are conducted outside of the body in a controlled environment, such as a laboratory, using specialized equipment and reagents. IVDs are crucial for diagnosing a wide range of health conditions, guiding treatment decisions, and monitoring patient health over time.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13065

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the In Vitro Diagnostics Market’s Growth Trajectory From 2025 To 2034?

The size of the in vitro diagnostics market has seen swift expansion in the last few years. Growth from $121.96 billion in 2024 to $136.55 billion in 2025, delineates a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth during the historic period include the advent of automated analyzers and molecular diagnostics, an aging population, disease outbreaks, healthcare regulations, and personalized medicine.

In the forthcoming years, the size of the in vitro diagnostics market is anticipated to witness substantial growth, expanding to a valuation of $214.88 billion by 2029 with a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth during the projected period include precision medicine, point-of-care testing, advancements in digital health and data analytics, and readiness for pandemics. Prominent trends influencing the forecast period involve technological advancements, incorporation of digital health, individualized diagnostics, testing kits for home use, and molecular diagnostics.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

Which Factors and External Forces Are Driving Demand in the In Vitro Diagnostics Market?

The increasing interest in self-administered testing kits is predicted to stimulate the expansion of the in vitro diagnostics market. These kits are medical or diagnostic tools that individuals can utilize themselves, without the assistance of healthcare professionals or trained personnel at home. They enhance accessibility by providing users the ability to carry out diagnostic tests at their convenience at home which could heighten the demand for testing, particularly for conditions that have not been diagnosed previously. For example, the Centers for Disease Control and Prevention, a US-based national public health agency, recorded a substantial surge in the utilization of at-home COVID-19 tests among US adults aged 18 or older between the Delta-dominant phase (August to December 2021) and the Omicron-dominant phase (December to March 2022). The self-reported use of at-home tests among those presenting COVID-19-like symptoms increased from 5.7% to 20.1%. Thus, the growing appeal of self-administered test kits is expected to fuel the advancement of the in vitro diagnostics market.

Which Segments in the In Vitro Diagnostics Offer the Most Growth?

The in vitro diagnosticsmarket covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the In Vitro Diagnostics Market?# Market?

North America was the largest region in the global in-vitro diagnostics market in 2024. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Which Cutting-Edge Market Trends Are Expected to Drive theIn Vitro Diagnostics Market’s Growth?

Leading enterprises in the in vitro diagnostics market are concentrating their efforts on creating novel products like the Cobas pulse system, to boost their market profitability. The Cobas pulse system, equipped with mobile digital health technology, is a professional tool for managing blood sugar levels and enhancing patient care. In January 2022, Roche Diagnostics, a US-based firm known for its ground-breaking products and services that cover a spectrum from disease prevention and diagnosis to monitoring, screening, and treatment, unveiled the Cobas pulse system. This portable gadget comes with an automatic glucose test strip reader, a camera, and a touchscreen to log additional diagnostic information. Its easy-to-use interface, designed for simple deployment, provides handy features that streamline operations, conserve time and optimize workflows.

View the full report here:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

What Are the Key Elements That Define the In Vitro Diagnostics Market?

In vitro diagnostics (IVD) refer to tests and procedures performed on biological samples, such as blood, tissue, or urine, taken from the human body to detect diseases, conditions, or infections. These tests are conducted outside of the body in a controlled environment, such as a laboratory, using specialized equipment and reagents. IVDs are crucial for diagnosing a wide range of health conditions, guiding treatment decisions, and monitoring patient health over time.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13065

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The In Vitro Diagnostics Market Expected to Grow Between 2025 And 2029?

Over the past few years, the in-vitro diagnostics market has seen substantial growth. The market is set to rise from a value of $130.74 billion in 2024 to $149.01 billion in 2025, with a compound annual growth rate (CAGR) of 14.0%. Factors that contributed to the growth during the historic period include the introduction of automated analyzers and molecular diagnostics, an ageing population, outbreaks of disease, healthcare regulations and the emergence of personalized medicine.

What Growth Rate Is Anticipated for the In Vitro Diagnostics Market in the Coming Years?

Expectations are high for swift expansion in the in-vitro diagnostics market over the coming years. The predicted increase indicates a rise to $232.69 billion by 2029 with a compound annual growth rate (CAGR) of 11.8%. This growth during the forecast period is attributed to various factors including precision medicine, point-of-care testing, digital health, and data analytics as well as pandemic preparedness. Anticipated trends over the forecast period include technological advances, integration of digital health, personalized diagnostics, home testing kits, and molecular diagnostics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

Who Are the Leading Companies in the In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

What Are the Key Drivers of the In Vitro Diagnostics Market?

The surge in the usage of self-administered test kits is predicted to stimulate the growth trend of the in vitro diagnostics market. These kits, which are intended for personal use without the assistance of medical specialists or trained staff, allow individuals to conduct their own diagnostic tests at home. This increases accessibility by facilitating diagnostic tests at home, providing convenience and potentially boosting the need for testing, especially for hitherto undiagnosed diseases. For instance, the Centers for Disease Control and Prevention, a national public health agency in the US, reported a notable rise in the usage of at-home COVID-19 tests among U.S. adults aged 18 and over, from the Delta-dominant phase (August to December 2021) to the Omicron-dominant phase (December to March 2022), in April 2022. The use of home tests among individuals who reported COVID-19-like symptoms increased from 5.7% to 20.1%. Therefore, the growing popularity of self-administered test kits will fuel the expansion of the in vitro diagnostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

What Are the Key Market Segments in the In Vitro Diagnostics Industry?

The in vitro diagnostics market covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

What Are the Latest Trends in the In Vitro Diagnostics Market?

Key players in the in vitro diagnostics market are concentrating their efforts on creating innovative products such as the Cobas pulse system, with the goal of boosting their market profitability. The Cobas pulse system offers a professional solution for managing blood glucose levels, utilizing mobile digital health capabilities to elevate patient care. As a case in point, in January 2022, Roche Diagnostics, an American company known for their progressive products and services pertaining to disease prevention, diagnosis, monitoring, screening, and treatment, introduced the Cobas pulse system. Equipped with an automated glucose test strip reader, a camera, and a touchscreen, this portable device allows for the capture of additional diagnostic data. With its easy-to-use interface, it is designed for seamless usage, offering features that simplify procedures, optimize time, and boost workflow efficiency.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

What Are the Key Regional Markets in the In Vitro Diagnostics Industry?

North America was the largest region in the global in-vitro diagnostics market in 2023. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13065

This Report Delivers Insight On:

1. How big is the in vitro diagnostics market, and how is it changing globally?

2. Who are the major companies in the in vitro diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the in vitro diagnostics market right now?

4. Which products or customer segments are growing the most in the in vitro diagnostics market?

5. What factors are helping or slowing down the growth of the in vitro diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the in vitro diagnostics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Are the Key Projections for the CAGR of the In Vitro Diagnostics Market Size From 2025 to 2034?

The market size for in-vitro diagnostics has been experiencing swift expansion in the past few years. From $130.74 billion in 2024, it is projected to rise to $149.01 billion in 2025, boasting a compound annual growth rate (CAGR) of 14.0%. This significant growth in the historic period is due to the introduction of automated analyzers and molecular diagnostics, an increase in the elderly population, occurrence of disease outbreaks, healthcare legislations, and the rise of personalized medicine.

The market size for in-vitro diagnostics is anticipated to witness a significant surge in the coming years, expanding to a hefty $232.69 billion in 2029 at a Compound Annual Growth Rate (CAGR) of 11.8%. Factors contributing to this growth throughout the forecasted period include precision medicine, point-of-care testing, digital health and data analytics, and preparedness for pandemics. The forecasted period is also expected to see key trends such as technological developments, the integration of digital health, customized diagnostics, at-home testing kits, and molecular diagnostics.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What Are the Core Growth Drivers Propelling the In Vitro Diagnostics Market Forward?

The surge in favorability for self-administered test kits is predicted to fuel the expansion of the in vitro diagnostics market. These test kits are medical or diagnostic tools, created for individuals to employ on their own, eliminating the necessity for healthcare experts or skilled workers to conduct the test at home. Such kits increase accessibility by allowing individuals to carry out diagnostic tests in the comfort of their homes, providing convenience and potentially amplifying the desire for testing, especially for conditions that were previously undiagnosed. For example, in April 2022, the Centers for Disease Control and Prevention, a US national public health institution, observed a marked escalation in the employment of at-home COVID-19 tests among American adults aged 18 and above from the Delta-dominant phase (August to December 2021) to the Omicron-dominant phase (December to March 2022). The utilization of at-home tests among participants showing COVID-19-like symptoms rose from 5.7% to 20.1%. Thus, the escalating favorability of self-administered test kits is poised to stimulate the expansion of the in vitro diagnostics market.

What Segment Types Define the In Vitro Diagnostics Market Structure?

The in vitro diagnostics market covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the In Vitro Diagnostics Market?

North America was the largest region in the global in-vitro diagnostics market in 2023. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

What Are the Strategic Trends Steering the In Vitro Diagnostics Market Direction?

Key players in the in vitro diagnostics market are concentrating on the development of innovative products such as the Cobas pulse system, to enhance their market profitability. The Cobas pulse system is a high-quality blood glucose management tool with mobile digital health features to optimize patient treatment. For example, Roche Diagnostics, an American firm specializing in the creation of innovative products and services for disease prevention, diagnosis, monitoring, screening, and treatment, unveiled the Cobas pulse system in January 2022. This portable device comes with an automated glucose test strip reader, a camera, and a touchscreen for logging supplementary diagnostic information. Its easy-to-use interface facilitates seamless integration, offering convenient features that simplify operations, save time and boost workflow efficiency.

View the full report here:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

What Is the Definition of the In Vitro Diagnostics Market?

In vitro diagnostics (IVD) refer to tests and procedures performed on biological samples, such as blood, tissue, or urine, taken from the human body to detect diseases, conditions, or infections. These tests are conducted outside of the body in a controlled environment, such as a laboratory, using specialized equipment and reagents. IVDs are crucial for diagnosing a wide range of health conditions, guiding treatment decisions, and monitoring patient health over time.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13065

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Factors Are Propelling the Market Growth of theIn Vitro Diagnostics Market from 2025 to 2034?

The rising demand for self-administered test kits is contributing to the growth of the in vitro diagnostics market. These test kits allow individuals to perform diagnostic tests at home, making testing more accessible and convenient. For example, the CDC observed a significant increase in the use of at-home COVID-19 tests among U.S. adults during the Omicron wave. The popularity of these self-test kits is driving market growth in in vitro diagnostics.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

#What Are the Key Projections for the CAGR of the In Vitro Diagnostics Market From 2025 to 2034?

The in-vitro diagnostics market has grown rapidly in recent years. It will grow from $130.74 billion in 2024 to $149.01 billion in 2025, at a CAGR of 14.0%. The historical growth is attributed to developments in automated analyzers and molecular diagnostics, the aging population, disease outbreaks, healthcare regulations, and personalized medicine.

The in-vitro diagnostics market is expected to experience rapid growth, reaching $232.69 billion by 2029 at a CAGR of 11.8%. The growth is due to the rise of precision medicine, point-of-care testing, digital health and data analytics, and pandemic preparedness. Key trends include technological advancements, digital health integration, personalized diagnostics, home testing kits, and molecular diagnostics.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13065

How Are Consumer Market Innovations Shaping the Current and Future Landscape of theIn Vitro Diagnostics Market?

Leading companies in the in vitro diagnostics market are introducing innovative products, such as the Cobas pulse system, to strengthen their market position. The Cobas pulse system, a portable blood glucose management device with digital health capabilities, aims to enhance patient care. For instance, Roche Diagnostics, a US-based developer, launched the Cobas pulse system in January 2022. This portable device features an automated glucose test strip reader, a camera, and a touchscreen to record additional diagnostic data, offering an intuitive interface that streamlines processes and improves workflows.

Which Key Market Players Are Shaping the Future and Growth of theIn Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

What Are the Core Segments of the In Vitro Diagnostics Market, and How Do They Contribute to Growth?

The in vitro diagnostics market covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

What Regions Are Dominating the In Vitro Diagnostics Market Growth?

North America was the largest region in the global in-vitro diagnostics market in 2023. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Reports Similar to the Global In Vitro Diagnostics Market 2025, By The Business Research Company:

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Hearing Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hearing-diagnostic-devices-and-equipment-global-market-report

Hematology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the in vitro diagnostics market grown over the years?

The market size for in-vitro diagnostics has experienced substantial growth in the previous years. It’s projected to rise from $130.74 billion in 2024 to $149.01 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.0%. The historic period’s growth is owing to the emergence of automated analyzers and molecular diagnostics, an increase in the elderly population, disease outbreaks, healthcare legislation, and precision medicine.

What Is the forecasted market size and growth rate for the in vitro diagnostics market?

The market size for in-vitro diagnostics is anticipated to experience a swift expansion in the upcoming years, scaling up to $232.69 billion by 2029 with a compound annual growth rate (CAGR) of 11.8%. Factors that are contributing to the projected growth within this forecast period include advances in precision medicine, point-of-care testing, digital health and data analytics, and readiness for pandemics. Key trends for the forecast period are expected to be technological innovation, integration with digital health, tailored diagnostics, home testing kits and molecular diagnostics.

Get your in vitro diagnostics market report here!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What are the major factors driving growth in the in vitro diagnostics market?

The growing trend of using self-administered test kits is poised to boost the in vitro diagnostics market’s expansion. These kits are medical or diagnostic tools that individuals can use independently without requiring healthcare experts or trained staff to facilitate the test at home. The kits improve access by allowing people to carry out these diagnostic tests at their homes, providing comfort and possibly amplifying the demand for testing, specifically for conditions previously unidentified. For example, data from the United States-based national public health agency, the Centers for Disease Control and Prevention, showed a notable rise in the usage of at-home COVID-19 tests amongst U.S. adults aged 18 and above, from the Delta-dominated period (August to December 2021) to the Omicron-dominated period (December to March 2022) in April 2022. The utilization of at-home tests amongst participants who noticed COVID-19-like symptoms rose from 5.7% to 20.1%. As such, the increasing preference for self-administered test kits will fuel the in vitro diagnostics market’s growth.

What key areas define the segmentation of the global in vitro diagnostics Market?

The in vitro diagnostics market covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What are the top market players propelling the growth of the in vitro diagnostics industry?

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

What are the key trends shaping the future of the in vitro diagnostics market?

In an attempt to bolster their profitability, key players in the in vitro diagnostics market are concentrating on the creation of innovative products like the Cobas pulse system. The Cobas pulse system is an advanced professional blood sugar management solution enriched with mobile digital health functionalities to elevate the level of patient care. For example, in January 2022, Roche Diagnostics, an American company known for its pioneering products and services aimed at disease prevention, diagnosis, monitoring, screening, and treatment, introduced the Cobas pulse system. This compact device comes with an automatic glucose test strip reader, a camera, and a touchscreen for capturing additional diagnostic information. The easy-to-use interface is conceived for seamless adoption and includes handy features that reduce work, save time, and improve working procedures.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13065

What regions are dominating the in vitro diagnostics market growth?

North America was the largest region in the global in-vitro diagnostics market in 2023. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Hearing Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hearing-diagnostic-devices-and-equipment-global-market-report

Hematology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What Growth Opportunities are Expected to Drive the In Vitro Diagnostics Market’s CAGR Through 2034?

The market size for in-vitro diagnostics has experienced substantial growth in the previous years. It’s projected to rise from $130.74 billion in 2024 to $149.01 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 14.0%. The historic period’s growth is owing to the emergence of automated analyzers and molecular diagnostics, an increase in the elderly population, disease outbreaks, healthcare legislation, and precision medicine.

The market size for in-vitro diagnostics is anticipated to experience a swift expansion in the upcoming years, scaling up to $232.69 billion by 2029 with a compound annual growth rate (CAGR) of 11.8%. Factors that are contributing to the projected growth within this forecast period include advances in precision medicine, point-of-care testing, digital health and data analytics, and readiness for pandemics. Key trends for the forecast period are expected to be technological innovation, integration with digital health, tailored diagnostics, home testing kits and molecular diagnostics.

What External and Internal Drivers Are Contributing to the Growth of the In Vitro Diagnostics Market’s Growth?

The growing trend of using self-administered test kits is poised to boost the in vitro diagnostics market’s expansion. These kits are medical or diagnostic tools that individuals can use independently without requiring healthcare experts or trained staff to facilitate the test at home. The kits improve access by allowing people to carry out these diagnostic tests at their homes, providing comfort and possibly amplifying the demand for testing, specifically for conditions previously unidentified. For example, data from the United States-based national public health agency, the Centers for Disease Control and Prevention, showed a notable rise in the usage of at-home COVID-19 tests amongst U.S. adults aged 18 and above, from the Delta-dominated period (August to December 2021) to the Omicron-dominated period (December to March 2022) in April 2022. The utilization of at-home tests amongst participants who noticed COVID-19-like symptoms rose from 5.7% to 20.1%. As such, the increasing preference for self-administered test kits will fuel the in vitro diagnostics market’s growth.

Get Your Free Sample of the Global In Vitro Diagnostics Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

What Are the Leading Industry Players Dominating the In Vitro Diagnostics Market?

Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

What Are the Key Trends to Watch in the In Vitro Diagnostics Market Over the Coming Years?

In an attempt to bolster their profitability, key players in the in vitro diagnostics market are concentrating on the creation of innovative products like the Cobas pulse system. The Cobas pulse system is an advanced professional blood sugar management solution enriched with mobile digital health functionalities to elevate the level of patient care. For example, in January 2022, Roche Diagnostics, an American company known for its pioneering products and services aimed at disease prevention, diagnosis, monitoring, screening, and treatment, introduced the Cobas pulse system. This compact device comes with an automatic glucose test strip reader, a camera, and a touchscreen for capturing additional diagnostic information. The easy-to-use interface is conceived for seamless adoption and includes handy features that reduce work, save time, and improve working procedures.

Get Instant Access to the Global In Vitro Diagnostics Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

Which Key Segments of the In Vitro Diagnostics Market Are Poised for Growth and Innovation?

The in vitro diagnostics market covered in this report is segmented –

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment

2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

3) By Type of Expenditure: Public, Private

4) By Product: Instruments/Equipment, Disposables

Subsegments:

1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing

2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)

3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing

4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices

5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems

6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers

7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters

8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

Which Regions Are Significant to the Growth of the In Vitro Diagnostics Market?

North America was the largest region in the global in-vitro diagnostics market in 2023. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

How Can We Define the In Vitro Diagnostics Market and Its Key Components?

In vitro diagnostics (IVD) refer to tests and procedures performed on biological samples, such as blood, tissue, or urine, taken from the human body to detect diseases, conditions, or infections. These tests are conducted outside of the body in a controlled environment, such as a laboratory, using specialized equipment and reagents. IVDs are crucial for diagnosing a wide range of health conditions, guiding treatment decisions, and monitoring patient health over time.

Browse Through More Similar Reports By The Business Research Company:

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cardiovascular-monitoring-and-diagnostic-devices-and-equipment-global-market-report

Hearing Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hearing-diagnostic-devices-and-equipment-global-market-report

Hematology Diagnostic Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/hematology-diagnostic-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: